Dolby Laboratories, Inc.
NYSE:DLBInformation Technology Services
-$0.10 today
- Market cap
- $5.51B
- Beta
- 0.80
- P/E (TTM)
- 20.0
- EPS (TTM)
- $2.56
- Dividend yield
- 2.76%
Volume 4.29M
Average 0.73M
DLB EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Dolby Laboratories, Inc.NYSE: DLB
EBITDA · Q4 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q4 FY2026 EBITDA of $94.57M rose 56.6% year over year, ahead of the +4.9% change in trailing-twelve-month EBITDA. Sequentially, it rose 49.3% from the prior quarter. Over 3 fiscal years it compounded at -4.2% a year.
Context
- EBITDA amounted to 21.4% of revenue in FY2026, down 6.7 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $610.13M (+100.7%) for the fiscal year ending Sep 2027, a step up from the -19.7% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $94.57M+49.3% QoQ
- Last fiscal yearSep 2026
- $303.99M-19.7% YoY
- LTMSep 2026
- $406.99M+4.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +56.6% | +47.3% | -9.3 pp |
| 1 year | -19.7% | +100.7% | +120.4 pp |
| 3-year CAGR | -4.2% | +34.0% | +38.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- 303.99M USD
- Year-over-year change
- -19.7%
- 4-year CAGR
- -1.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-09-25 | 303.99M | -19.7% |
| FY2025 | 2025-09-26 | 378.56M | -5.3% |
| FY2024 | 2024-09-27 | 399.81M | +15.7% |
| FY2023 | 2023-09-29 | 345.57M | +8.4% |
| FY2022 | 2022-09-30 | 318.89M | — |
EBITDA vs competitors
How DLB compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +4.9% is the 7th highest of 11, against a peer median of +9.1%.
- EBITDA amounts to 28.6% of revenue for DLB, versus a peer median of 21.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥5.62B CNY | -5.5% | +89.1% | 45.9% | |
| LTM Jun 2026 | $2.37B USD | -3.8% | +74.5% | 9.0% | |
INGMIngram Micro Holding Corporation | LTM Jun 2026 | $1.3B USD | +22.5% | -30.4% | 2.3% |
| LTM Jun 2026 | $912.8M USD | +111.9% | +44.9% | 19.1% | |
| LTM Sep 2026 | $894.32M USD | +1.6% | +10.2% | 16.7% | |
| LTM Jun 2026 | $553.87M USD | +6.2% | +18.9% | 27.0% | |
| LTM Jun 2026 | $441.01M USD | +12.1% | +12.4% | 19.7% | |
| LTM Jun 2026 | $432.42M USD | +15.2% | +12.7% | 35.9% | |
| LTM Sep 2026 | $406.99M USD | +4.9% | -4.2% | 28.6% | |
| LTM Sep 2026 | $298.39M USD | +21.3% | -10.0% | 22.7% | |
| LTM Jun 2026 | $257.54M USD | -19.4% | -1.7% | 42.4% | |
| Peer median (excluding DLB) | — | +9.1% | +12.5% | 21.2% | |
Competitors are the stored peer set for DLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 | FY2026 Sep 2026 |
|---|---|---|---|---|---|
| Revenue | 1.25B | 1.3B | 1.27B | 1.35B | 1.42B |
| Cost of Revenue | 141.36M | 152.57M | 140.5M | 160.13M | 186.5M |
| Gross Profit | 1.11B | 1.15B | 1.13B | 1.19B | 1.23B |
| Gross Margin | 88.7% | 88.3% | 89.0% | 88.1% | 86.9% |
| Research & Development | 261.17M | 271.52M | 263.66M | 261.79M | 262.78M |
| Selling, General & Admin | 634.03M | 612.84M | 604.85M | 647.24M | 651.6M |
| Operating Expenses | 895.21M | 884.36M | 868.52M | 924.04M | 914.38M |
| Depreciation & Amortization | 103.61M | 95.51M | 87.33M | 98.6M | 0 |
| EBITDA | 318.89M | 345.57M | 399.81M | 378.56M | 303.99M |
| EBITDA Margin | 25.4% | 26.6% | 31.4% | 28.1% | 21.4% |
| Operating Income | 217.23M | 262.81M | 264.71M | 264.96M | 303.99M |
| Operating Margin | 17.3% | 20.2% | 20.8% | 19.6% | 21.4% |
| Interest Income | 6.57M | 28.09M | 34.08M | 15.38M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 16.67M |
| Other Income / Expenses | (1.95M) | (12.76M) | 47.77M | 38.53M | 33.39M |
| Income Before Tax | 215.28M | 250.05M | 312.48M | 303.49M | 337.38M |
| Pre-Tax Margin | 17.2% | 19.2% | 24.5% | 22.5% | 23.7% |
| Income Tax Expense | 31.38M | 48.41M | 48.16M | 46.99M | (77.86M) |
| Net Income | 184.09M | 200.66M | 261.83M | 255.02M | 257.74M |
| Net Margin | 14.7% | 15.4% | 20.6% | 18.9% | 18.1% |
| EPS (Basic) | 1.84 | 2.00 | 2.74 | 2.66 | 2.73 |
| EPS (Diluted) | 1.81 | 1.96 | 2.69 | 2.62 | 2.70 |
| Weighted Avg Shares | 99.99M | 95.79M | 95.54M | 95.87M | 94.57M |
| Weighted Avg Shares (Diluted) | 101.98M | 97.59M | 97.33M | 97.48M | 95.59M |
Dolby Laboratories, Inc.
NYSE:DLB
Intrinsic Alpha fair value
Locked
Current Price
$58.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.